Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

Taisuke Imamura(Kyoto Prefectural University of Medicine), Eigo Otsuji(Kyoto Prefectural University of Medicine)
Scientific Reports
July 12, 2017
Cited by 58


Related Papers